BPLPHARMA

Bharat Parenterals Ltd.

BSE: 541096

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,380.00+4.9 (+0.36%)

12 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

14.0 / 100

Value Score

11.8 / 100

Price Momentum Score

78.0 / 100

QVM Score

18.8 / 100

Key Metrics

Market Cap

951.10

P/E (TTM)

P/B

2.95

P/S (TTM)

2.94

EV/EBITDA

101.77

CAPE (5Y)

179.41

ROE (TTM)

-2.51

ROCE (TTM)

-3.77

ROA (TTM)

-1.30

Avg 3Y ROE

0.12

Earnings 3Y CAGR

-40.79

Sales 3Y CAGR

7.27

Sales 5Y CAGR

8.94

Debt/Equity

0.45

Consensus TP

Strong Buy %

Promoter Holding

67.20

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Bharat Parenterals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 78.0 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

78.0 / 100

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.45 as on 30 Jun 2026 and Debt to Equity decreased marginally by 0.09 in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 3 financial years

What is Dividend streak?

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -1.62% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low but stable operating margin

The company reported low operating margin of -7.35% for 12-month ended 30 Jun 2026 and operating margin declined marginally by -105 bps from 1 year ago

What is Operating profit margin?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of -11.18% for 12-month ended 30 Jun 2026 and the growth was 23.26 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 12.08

Value -11.18

-42.894040.18

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -237.57% for 12-month ended 30 Jun 2026 and the growth was 247.66 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.07%

What is Dividend yield?

Neutral

Low ROE but improving trend

The company reported low ROE of -2.51% for 12-month ended 30 Jun 2026 but ROE improved by 226 bps from 1 year ago

What is ROE (FY)?

Company's earnings are of moderate quality

Earnings quality score of 54.0 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

54.0 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Bharat Parenterals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Bharat Parenterals Ltd. Shareholding Pattern

Quarterly breakdown of Bharat Parenterals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	74.42	74.42	74.42	74.42	74.42	74.42	74.42	74.42	73.84	73.84	73.84	73.84	73.84	73.84	73.84	73.84	73.27	73.27	65.35	67.20	67.20	67.19	67.19	67.19	67.17	67.20
Indian Promoter	74.42	74.42	74.42	74.42	74.42	74.42	74.42	74.42	26.54	73.84	73.84	73.84	73.84	73.84	73.84	73.84	73.27	73.27	65.35	67.20	67.20	67.19	67.19	67.19	67.17	67.20
Foreign Promoter	-	-	-	-	-	-	-	-	47.30	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.66	0.65	0.65	0.65	0.65	0.65	1.17	1.48
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.09	0.11	0.11	0.11	0.11	0.11	0.11	0.11
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.56	0.53	0.53	0.53	0.53	0.53	1.06	1.37
Non-Institution	25.57	25.57	25.57	25.57	25.57	25.57	25.57	25.57	26.15	26.15	26.15	26.15	26.15	26.15	26.15	26.15	26.73	26.73	33.99	32.15	32.15	32.16	32.15	32.15	31.66	31.31
Bodies Corporate	6.76	6.64	6.58	6.89	1.19	1.30	7.41	7.75	8.19	8.16	8.73	8.21	8.21	8.21	8.38	8.37	8.43	8.24	9.15	8.47	8.46	8.26	8.23	8.25	8.20	8.23
Others (incl. Retail) No. of shareholders	18.81 1,448	18.93 1,736	18.99 2,282	18.68 2,683	24.38 2,549	24.27 3,094	18.16 2,883	17.82 2,776	17.96 2,767	17.99 2,736	17.42 2,669	17.94 2,578	17.94 2,486	17.94 2,457	17.77 2,454	17.78 2,371	18.30 2,463	18.49 2,668	24.84 2,705	23.68 3,063	23.69 3,124	23.90 3,178	23.92 3,145	23.90 3,112	23.46 3,041	23.08 3,002

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Bharat Parenterals Ltd. is not part of any tracked index.

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Bharat Parenterals Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Neo Apex Share Broking Services Llp	28 Feb 2025	sell	₹ 878.00	75.27 k	₹ 6.61 cr
Setu Securities Private Limited	28 Feb 2025	buy	₹ 878.00	75.27 k	₹ 6.61 cr

Corporate Actions

History of Bharat Parenterals Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 1/share
Record date: 19th Sep 2025Ex-date: 19th Sep 2025
Announced on: 12th May 2025
Dividend₹ 1/share
Record date: 25th Jun 2024Ex-date: 25th Jun 2024
Announced on: 22nd May 2024
Dividend₹ 0.75/share
Record date: 25th Sep 2023Ex-date: 25th Sep 2023
Announced on: 20th May 2023

Company Profile

Overview of Bharat Parenterals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Bharat Parenterals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing generic and specialty formulations. The Company offers a range of products, including antibiotics, anaesthetics, quinolones, antifungal, analgesic, antimalarial, cardiovascular system, centra...

Key personnel

Mr. Jignesh Nitinchandra Shah

Chief Financial Officer

Mr. Sharmin Nareshkumar Soni

Company Secretary and Compliance Officer

Mr. Bharatkumar Rameshchandra DesaiD

Managing Director, Executive Chairman of the Board

Mr. Hemang Jayendrabhai ShahD

Executive Director

Mr. Alkesh ShahD

Additional Non-Executive Director

Mr. Shaileshkumar GabhawalaD

Non-Executive Independent Director

Mr. Mukesh Jivrajbhai PatelD

Non-Executive Independent Director

Mrs. Zankhana Bimalkumar ShethD

Non-Executive Independent Director

Incorporated on

03 Sep 1992

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

21 Mar 2018

Free Float

13,96,270

Website

https://bplindia.in/

Phone no.

+919909928332

Address

Survey No 144 To 146, Jarod Samlaya Road, Village Haripura, Taluka Savli, VADODARA, India

Frequently Asked Questions

What is the current share price of Bharat Parenterals Ltd.?

The current share price of Bharat Parenterals Ltd. is ₹ 1,380.00 as of 12 Aug 2026.

What is the market capitalisation of Bharat Parenterals Ltd.?

The market capitalisation of Bharat Parenterals Ltd. stands at ₹ 951.10 Cr.

What is the PE ratio of Bharat Parenterals Ltd.?

The Price-to-Earnings (PE) ratio of Bharat Parenterals Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Bharat Parenterals Ltd.?

Bharat Parenterals Ltd. has a Return on Equity (ROE) of -2.51% and a Return on Capital Employed (ROCE) of -3.77% as per the latest financial reports.

What is the 52-week high and low of Bharat Parenterals Ltd.?

The 52-week high of Bharat Parenterals Ltd. is - and the 52-week low is -.

What is the dividend yield of Bharat Parenterals Ltd.?

The dividend yield of Bharat Parenterals Ltd. is 0.07% based on the current market price.

What is the FII and DII holding in Bharat Parenterals Ltd.?

Foreign Institutional Investors (FII) hold 0.11%, Domestic Institutional Investors (DII) hold 0.01% and retail/public investors hold 23.08% of Bharat Parenterals Ltd. shares.

What sector does Bharat Parenterals Ltd. belong to?

Bharat Parenterals Ltd. operates in the Healthcare sector.

What is the beta of Bharat Parenterals Ltd.?

The beta of Bharat Parenterals Ltd. is 0.76, indicating its price volatility relative to the broader market. Over the past 1 year, Bharat Parenterals Ltd. has delivered an absolute return of -8.00%.

What is the RSI of Bharat Parenterals Ltd.?

The 14-day Relative Strength Index (RSI) of Bharat Parenterals Ltd. is 45.71, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Bharat Parenterals Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Bharat Parenterals Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Holdings and Presence

Stock Analysis

Corporate Actions

Company Profile